Announcement of Changes in the Board of Managementof PT Bio Farma (Persero)

Bandung, September 4, 2025 – PT Bio Farma (Persero), the holding company of the State-Owned Pharmaceutical Enterprises (BUMN Farmasi) and the largest vaccine and biotechnology producer in Southeast Asia, officially announces changes in its Board of Management.
The change is based on the Decree of the Minister of State-Owned Enterprises of the Republic of Indonesia and the President Director of PT Danantara Asset Management (Persero) dated September 4, 2025, effective as of August 24, 2025.
The updated composition of Bio Farma’s Board of Management is as follows:
Board of Directors
President Director : Shadiq Akasya
Director of Finance & Risk Management : I.G.N Suharta Wijaya
Director of Production & Supply Chain : Sri Harsi Teteki
Director of Human Capital : Iin Susanti
Director of Sales : Kamelia Faisal
Director of Research & Development : Yuliana Indriati
Board of Commissioners
President Commissioner / Independent Commissioner : Tugas Ratmono
Independent Commissioner : Batara Imanuel Sirait
Independent Commissioner : Nizar Yamanie
Commissioner : Roni Dwi Susanto
Commissioner : Didik Kusnaini
Commissioner : Relly Reagen
Commissioner : Pritta Basuki
--o0o--
For Media Information, Contact :
Corporate Communication
PT Bio Farma (Persero)
corcom@biofarma.co.id
ID
EN